Stocktoria

ProMIS Neurosciences Inc. PMN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-04-03 · LEI

ProMIS Neurosciences Inc. statistics & valuation

Market cap$22.7M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20212022202320242025
Operating margin (%)
20212022202320242025
Return on equity (%)
-173.00% -352.00% 16.90% 20212022202320242025
Shares outstanding
7.2M 8.6M 18.9M 1.3M 2.2M 20212022202320242025
Net debt ($)
-$13.0M -$12.6M 20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-55.20% -260.80% -97.00% 14.70% -432.60% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
0.69× 0.00× 20212022202320242025
EPS ($)
-$1.69 -$2.41 -$1.07 $2.63 -$22.61 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-432.6%14.7%-97.0%-260.8%-55.2%
Return on equity3155.8%16.9%-352.0%1340.2%-173.0%
Debt / equity——0.00×—0.69×
Current ratio0.888.521.461.0819.07

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.